{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Daily Paper Cast","title":"Towards an AI co-scientist","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/01f1ac62\"></iframe>","width":"100%","height":180,"duration":1503,"description":"\n            🤗 Upvotes: 15 | cs.AI, cs.CL, cs.HC, cs.LG, physics.soc-ph, q-bio.OT\n\n            Authors:\n            Juraj Gottweis, Wei-Hung Weng, Alexander Daryin, Tao Tu, Anil Palepu, Petar Sirkovic, Artiom Myaskovsky, Felix Weissenberger, Keran Rong, Ryutaro Tanno, Khaled Saab, Dan Popovici, Jacob Blum, Fan Zhang, Katherine Chou, Avinatan Hassidim, Burak Gokturk, Amin Vahdat, Pushmeet Kohli, Yossi Matias, Andrew Carroll, Kavita Kulkarni, Nenad Tomasev, Yuan Guan, Vikram Dhillon, Eeshit Dhaval Vaishnav, Byron Lee, Tiago R D Costa, José R Penadés, Gary Peltz, Yunhan Xu, Annalisa Pawlosky, Alan Karthikesalingam, Vivek Natarajan\n\n            Title:\n            Towards an AI co-scientist\n\n            Arxiv:\n            http://arxiv.org/abs/2502.18864v1\n\n            Abstract:\n            Scientific discovery relies on scientists generating novel hypotheses that undergo rigorous experimental validation. To augment this process, we introduce an AI co-scientist, a multi-agent system built on Gemini 2.0. The AI co-scientist is intended to help uncover new, original knowledge and to formulate demonstrably novel research hypotheses and proposals, building upon prior evidence and aligned to scientist-provided research objectives and guidance. The system's design incorporates a generate, debate, and evolve approach to hypothesis generation, inspired by the scientific method and accelerated by scaling test-time compute. Key contributions include: (1) a multi-agent architecture with an asynchronous task execution framework for flexible compute scaling; (2) a tournament evolution process for self-improving hypotheses generation. Automated evaluations show continued benefits of test-time compute, improving hypothesis quality. While general purpose, we focus development and validation in three biomedical areas: drug repurposing, novel target discovery, and explaining mechanisms of bacterial evolution and anti-microbial resistance. For drug repurposing, the system proposes...","thumbnail_url":"https://img.transistorcdn.com/8lOVNnuwhrA3rxrDMv7Osu4j_t1-jORooO6NfGcQhcw/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81Zjg1/YzRhODczMDU4MmE4/OGMwN2FiNDlmYzI2/MDliMi5qcGVn.webp","thumbnail_width":300,"thumbnail_height":300}